Why the study?
Do synthetic peptide vaccines induce homotypic and heterotypic protection against foot-and-mouth disease virus in cattle and guinea pigs?
Do synthetic peptide vaccines induce homotypic and heterotypic protection against foot-and-mouth disease virus in cattle and guinea pigs?
Synthetic peptide vaccines for foot-and-mouth disease can induce both homotypic and heterotypic protection in animal models, driven primarily by cross-reactive antipeptide antibodies.
Answers are grounded in this paper and cite their sources.
Supports peptide vaccine development for FMD; hypothesis-generating in guinea pigs and leaves open cattle translation.
Synthetic peptide vaccines of the general sequence Cys-Cys(200-213)-Pro-Pro-Ser-(141-158)-Pro-Cys-Gly, where the numbered residues refer to VP1 sequences of three different strains of foot-and-mouth disease virus, have been evaluated in cattle and guinea pigs. High levels of serotype-specific (homotypic) antiviral and antipeptide antibody were produced with each peptide. The A- and O-serotype peptides provided complete protection of guinea pigs against their respective virus challenges. The C-serotype peptide appeared to be less effective than the other peptides. In cross-protection studies (heterotypic) in guinea pigs, it was possible to protect A-serotype peptide-vaccinated animals against O-virus challenge and vice versa. Some heterotypic protection was also achieved with the C-serotype peptide. The heterotypic protection observed related more to the presence of cross-reactive antipeptide antibody than to neutralizing antibody.
No takes yet. Share an insight, caveat, or question.
Doel et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: